skip to content

Pegasys® (peginterferon alfa-2a)

Pharmaceutical Product Information

In May 2022, Roche transferred the sponsorship and management of supply, customer support, medical information, regulatory services, sales and marketing of Pegasys to Echo Therapeutics Pty Ltd in Australia. The current Consumer Medicine Information (CMI) and Product Information (PI) for Pegasys are available from the Therapeutic Goods Administration (TGA) website at: https://www.ebs.tga.gov.au/

Solutions

Pharma Products
See all Pharma Products